✦ LIBER ✦

Uveal Melanoma Treated With Iodine-125 Episcleral Plaque: An Analysis of Dose on Disease Control and Visual Outcomes

✍ Scribed by Perez, Bradford A.; Mettu, Pradeep; Vajzovic, Lejla; Rivera, Douglas; Alkaissi, Ali; Steffey, Beverly A.; Cai, Jing; Stinnett, Sandra; Dutton, Jonathan J.; Buckley, Edward G.; Halperin, Edward; Marks, Lawrence B.; Mruthyunjaya, Prithvi; Kirsch, David G.

Book ID: 122258896
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 1011 KB
Volume: 89
Category: Article
ISSN: 0360-3016
DOI: 10.1016/j.ijrobp.2014.01.026

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

125I plaque therapy for uveal melanoma:

125I plaque therapy for uveal melanoma: Analysis of the impact of time and dose factors on local control

✍ Jeanne M. Quivey; James Augsburger; Lesley Snelling; Luther W. Brady 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 725 KB

BACKGROUND. IZ5I episcleral plaque therapy has gained wide acceptance for the treatment of weal melanoma because of its potential to preserve vision, salvage the globe, and provide good local control. A rigorous analysis of the optimum radiation dose, dose rate, and overall treatment time has not be

125I plaque therapy for uveal melanoma.

125I plaque therapy for uveal melanoma. Analysis of the impact of time and dose factors on local control

✍ Quivey, JM; Augsburger, J; Snelling, L 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 281 KB